 |
 |
|
|
RESÚMENES MARZO 2007 |
Addictive Disorders
(Haga un click en la información del journal para acceder al resúmen)
Effect of Memantine on Cue-Induced Alcohol Craving in Recovering
Alcohol-Dependent Patients
Evgeny M. Krupitsky, Olga Neznanova, Dimitry Masalov, Andrey M. Burakov, Tatyana Didenko, Tatyana Romanova, Marina Tsoy, Anton Bespalov, Tatyana Y. Slavina, Alexander A. Grinenko, Ismene L. Petrakis,
Brian Pittman, Ralitza Gueorguieva,
Edwin E. Zvartau, and John H. Krystal
Am J Psychiatry 164:519-523, March 2007
Nucleus Accumbens D2/3 Receptors Predict Trait Impulsivity and
Cocaine Reinforcement
Jeffrey W. Dalley, Tim D. Fryer, Laurent Brichard,
Emma S. J. Robinson, David E. H. Theobald, Kristjan Lääne, Yolanda Peña, Emily R. Murphy, Yasmene
Shah, Katrin Probst, Irina Abakumova, Franklin I. Aigbirhio,
Hugh K. Richards, Young Hong, Jean-Claude Baron, Barry J. Everitt,
Trevor W. Robbins
Science 2 March 2007: Vol. 315. no. 5816, pp. 1267 - 1270
The
psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine):
an evidence-based review
A. C. Parrott
Psychopharmacology. Volume 191, Number 2 /
April, 2007:181-193
The debate over dopamine’s role in reward: the case for incentive
salience
Kent C. Berridge
Psychopharmacology. Volume 191, Number 3 / April, 2007:391-431
Opioids for hedonic experience and dopamine to get ready for it
M. Flavia Barbano and Martine Cador
Psychopharmacology. Volume 191, Number 3 / April, 2007:497-506
Nucleus Accumbens
D2/3 Receptors Predict Trait Impulsivity and Cocaine Reinforcement
Jeffrey
W. Dalley, Tim D. Fryer, Laurent Brichard,
Emma S. J. Robinson, David E. H. Theobald, Kristjan Lääne, Yolanda Peña, Emily R. Murphy, Yasmene
Shah, Katrin Probst, Irina Abakumova, Franklin I. Aigbirhio,
Hugh K. Richards, Young Hong, Jean-Claude Baron, Barry J. Everitt,
Trevor W. Robbins
Science 2 March 2007:Vol. 315. no.
5816, pp. 1267 - 1270
High-Dose Transdermal
Nicotine and Naltrexone: Effects on Nicotine
Withdrawal, Urges, Smoking, and Effects of Smoking
Damaris J. Rohsenow, Peter M. Monti, Kent E.
Hutchison, Robert M. Swift, Selene V. MacKinnon, Alan D. Sirota
and Gary B. Kaplan
Experimental and Clinical Psychopharmacology. Volume 15, Issue 1, February 2007, Pages 81-92
Naloxone
treatment in opioid addiction: the risks and benefits
Eveline LA van Dorp
, Ashraf Yassen & Albert Dahan
Expert Opinion on Drug Safety. March 2007, Vol. 6, No. 2, Pages 125-132
Identification of Patients at High Risk of
Noncompliance in Substance Dependence Treatment
G.H. de Weert-van Oene, H. Burger, D.E. Grobbee, A.J.P. Schrijvers
European
Addiction Research 2007;13:74-80
Developmental Outcome in Children
with Intrauterine Exposure to Substances
H.-C. Steinhausen,
B. Blattmann, F. Pfund
European
Addiction Research 2007;13:94-100
TREATING SUBSTANCE USE DISORDERS
APA Guidelines
Practice Guideline for the Treatment of Patients With Substance Use Disorders, Second
TEXTO GRATUITO
A developmental comparison of the neurobehavioral
effects of ecstasy (MDMA)
Brian J. Piper
Neurotoxicology and Teratology. Volume 29, Issue 2, March-April 2007, Pages 288-300
Abuse liability of buprenorphine–naloxone tablets in untreated IV drug users
Hannu Alho, David Sinclair, Erkki Vuori and Antti Holopainen
Drug and Alcohol Dependence. Volume 88, Issue 1, 17 April 2007, Pages 75-78
In-patient detoxification procedures,
treatment retention, and post-treatment opiate use: Comparison of lofexidine + naloxone, lofexidine + placebo, and methadone
J. McCambridge, M. Gossop,
T. Beswick, D. Best, J. Bearn, S. Rees and J. Strang
Drug and Alcohol Dependence. Volume 88, Issue 1, 17 April 2007, Pages 91-95
Antiglutamatergic
Strategies for Ethanol Detoxification: Comparison With Placebo and Diazepam
Evgeny M. Krupitsky,
Anatoly A. Rudenko, Andrey
M. Burakov, Tatyana Y. Slavina, Alexander A. Grinenko,
Brian Pittman, Ralitza Gueorguieva,
Ismene L. Petrakis, Edwin E. Zvartau,
John H. Krystal
Alcoholism: Clinical and Experimental Research 2007;
31 (4), 604–611
Mental health outcomes following naltrexone implant treatment for heroin-dependence
Hanh T.T.
Ngo, Robert J. Tait, Diane E. Arnold-Reed and Gary K.
Hulse
Psychiatric
disorders in inhalant users: Results from The National
Epidemiologic Survey on Alcohol and Related Conditions
Li-Tzy Wu and Matthew Owen
Howard
Drug and Alcohol Dependence. Volume 88, Issues 2-3, 11
May 2007, Pages 146-155
Chronic benzylpiperazine (BZP) exposure produces behavioral
sensitization and cross-sensitization to methamphetamine (MA)
K. Brennan, A. Johnstone,
P. Fitzmaurice, R. Lea and S. Schenk
Drug and Alcohol Dependence. Volume 88, Issues 2-3, 11 May 2007, Pages 204-213
Safety,
tolerability and efficacy of levodopa–carbidopa treatment for cocaine dependence: Two
double-blind, randomized, clinical trials
Marc E. Mooney, Joy M. Schmitz, F. Gerard Moeller
and John Grabowski
Drug and Alcohol Dependence. Volume 88, Issues 2-3, 11 May 2007, Pages 214-223